Search Results - "Bose, Gauruv"

Serum neurofilament light in MS: The first true blood-based biomarker? by Thebault, Simon, Bose, Gauruv, Booth, Ronald, Freedman, Mark S

“…A simple blood-derived biomarker is desirable in the routine management of multiple sclerosis (MS) patients and serum neurofilament light chain (sNfL) is the…”
Get full text

Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment by Bose, Gauruv, Freedman, Mark S

“…Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system (CNS), affecting patients of all ages, causing neurologic disability…”
Get full text

Anti-CGRP therapies for migraine in multiple sclerosis patients by Gonzalez-Martinez, Alicia, Bose, Gauruv, Chitnis, Tanuja

Get full text

Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis by Bose, Gauruv, Atkins, Harold L, Bowman, Marjorie, Freedman, Mark S

“…Background: Fatigue is a common problem in multiple sclerosis (MS) affecting as many as 90% of patients. The Fatigue Impact Scale (FIS) is a validated measure…”
Get full text

Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review by Molazadeh, Negar, Bose, Gauruv, Lotan, Itay, Levy, Michael

“…Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has various similarities with AQP4-IgG-seropositive Neuromyelitis Optica…”
Get full text

Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective by Bose, Gauruv, Thebault, Simon, Rush, Carolina A, Atkins, Harold L, Freedman, Mark S

“…The most effective treatment at halting inflammation in patients with highly active multiple sclerosis (MS) is immune ablation followed by autologous…”
Get full text

Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis by Bose, Gauruv, Healy, Brian C, Barro, Christian, Moreira Ferreira, Vanessa F, Saxena, Shrishti, Glanz, Bonnie I, Lokhande, Hrishikesh A, Polgar-Turcsanyi, Mariann, Bakshi, Rohit, Weiner, Howard L, Chitnis, Tanuja

“…Background: Contrast-enhancing magnetic resonance imaging (MRI) lesions (CELs) indicate acute multiple sclerosis inflammation. Serum biomarkers, neurofilament…”
Get full text

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study by Gonzalez-Martinez, Alicia, Bose, Gauruv, Lokhande, Hrishikesh, Saxena, Shrishti, Healy, Brian C, Polgar-Turcsanyi, Mariann, Weiner, Howard L, Chitnis, Tanuja

“…Multiple sclerosis (MS) is a chronic demyelinating autoimmune disorder which may cause long-term disability. MicroRNA (miRNA) are stable, non-coding molecules…”
Get full text

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review by Bose, Gauruv, Graveline, Justin, Yogendrakumar, Vignan, Shorr, Risa, Fergusson, Dean A, Le Gal, Gregoire, Coutinho, Jonathan, Mendonça, Marcelo, Viana-Baptista, Miguel, Nagel, Simon, Dowlatshahi, Dar

“…ObjectivesCurrent guidelines do not recommend direct oral anticoagulants (DOACs) to treat cerebral venous thrombosis (CVT) despite their benefits over standard…”
Get full text

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol by Bose, Gauruv, Graveline, Justin, Yogendrakumar, Vignan, Fergusson, Dean, Dowlatshahi, Dar

“…Cerebral venous thrombosis causes disability from venous infarct and hemorrhage and potential mortality. Anticoagulation improves survival and disability…”
Get full text

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine by Conway, Sarah, Saxena, Shrishti, Baecher-Allan, Clare, Krishnan, Rajesh, Houtchens, Maria, Glanz, Bonnie, Saraceno, Taylor J, Polgar-Turcsanyi, Mariann, Bose, Gauruv, Bakshi, Rohit, Bhattacharyya, Shamik, Galetta, Kristin, Kaplan, Tamara, Severson, Christopher, Singhal, Tarun, Stazzone, Lynn, Zurawski, Jonathan, Paul, Anu, Weiner, Howard L, Healy, Brian C, Chitnis, Tanuja

“…Background There is limited knowledge about T cell responses in patients with multiple sclerosis (MS) after 3 doses of severe acute respiratory syndrome…”
Get full text

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis by Thebault, Simon, Lee, Hyunwoo, Bose, Gauruv, Tessier, Daniel, Abdoli, Mohammad, Bowman, Marjorie, Berard, Jason, Walker, Lisa, Rush, Carolina A., MacLean, Heather, Booth, Ronald A., Narayanan, Sridar, Arnold, Douglas L., Tabard‐Cossa, Vincent, Atkins, Harold L., Bar‐Or, Amit, Freedman, Mark S.

“…Objective Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple…”
Get full text

Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis by Bose, Gauruv, Galetta, Kristin

“…A 32-year-old woman with highly active MS was infected with SARS-CoV-2 while on treatment with rituximab. She recovered and was symptom-free for 21 days before…”
Get full text

Radiologic Disease Activity Independent of Relapses in Aquaporin4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder (AQP4-IgG+ NMOSD), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), and Multiple Sclerosis (MS): A Retrospective Comparative Study (S50.010) by Molazadeh, Negar, Bose, Gauruv, Chitnis, Tanuja, Levy, Michael

“…Abstract only…”
Get full text

Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis by Bose, Gauruv, Freedman, Mark S.

“…The judicious use of autologous hematopoietic stem cell transplantation (AHSCT) for MS requires understanding the potential benefits, identifying the most…”
Get full text

Patterns and Predictors of Multiple Sclerosis Phenotype Transitions: A Longitudinal Analysis Using the CLIMB Study (P5-3.018) by Bose, Gauruv, Greene, Nupur, Healy, Brian C., Weiner, Howard, Farnett, Lisa, Higuchi, Keiko, Chitnis, Tanuja

“…Abstract only…”
Get full text

Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study (P5-3.006) by Bose, Gauruv, Greene, Nupur, Healy, Brian, Weiner, Howard, Farnett, Lisa, Higuchi, Keiko, Chitnis, Tanuja

“…Abstract only…”
Get full text

Treatment at Onset Predicts a Longer Time-to-Relapse After Index Event in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (S40.009) by Molazadeh, Negar, Bilodeau, Philippe-Antoine, Salky, Rebecca, Bose, Gauruv, Chitnis, Tanuja, Levy, Michael

“…Abstract only…”
Get full text

Serum neurofilament light chain (NfL)and CSF glial fibrillary acidic protein (GFAP) together improve the prediction of long-term clinical outcomes in multiple sclerosis (S9.001) by Thebault, Simon, Fereshtehnejad, Seyed Mohammad, Bergman, Hailey, Bose, Gauruv, Freedman, Mark

“…Abstract only…”
Get full text

Clinical Reasoning: A 73-year-old man with recurrent aphasia, headaches, and confusion by Bose, Gauruv, Fitzpatrick, Tess, Yogendrakumar, Vignan, Zwicker, Jocelyn Christine, Jansen, Gerard

Get full text